BofA Securities, Inc. is the corporate and investment banking and capital markets arm of Bank of America, serving corporations, financial institutions, governments, and institutional investors globally. Operating under the BofA Securities brand, the firm provides services including mergers and acquisitions advisory, debt and equity underwriting, leveraged finance, syndicated loans, and capital raising. It also offers sales and trading across fixed income, currencies, commodities, and equities, as well as economic and sector research.
In the chemicals and materials sectors, BofA Securities advises on portfolio restructuring, cross-border M&A, carve-outs, and strategic partnerships; arranges public and private debt and equity financing; and supports risk management through derivatives and market access. The firm works with investment-grade and high-yield issuers, financial sponsors, and state-owned enterprises, leveraging a global distribution network and sector-focused coverage teams.
Also known as Bank of America Securities and BofAML Securities, Inc..
None yet. When a new project in the record names BofA Securities as owner, partner or investor, it shows here.
Restructures Bakken contracts to cut unit midstream costs ~50%, transfers midstream ownership and DJ Basin assets for improved terms plus $200M, expects a $3–4B one-time after-tax loss; close by year-end 2026.
Exclusive global licence for a preclinical oral KRAS G12D (ON) molecular‑glue inhibitor; $400M upfront and $2.13B total potential; Merck to lead development and commercialization.
Food Ingredients business sold for ~$4.3B (≈10x EBITDA); seller retains ~10% stake; net proceeds ~$3.8B for debt reduction, buybacks and reinvestment; close by end Q2 2027.
Ventyx's small molecule pipeline targets chronic inflammation in cardiometabolic, neurodegenerative, and inflammatory diseases, aiming for improved efficacy and safety.
Novo Nordisk acquires Akero for $4.7B, adding efruxifermin, a promising MASH treatment, to its portfolio. The deal includes a $0.5B contingent value right upon regulatory approval.
Solvay ties borrowing costs to GHG reduction targets, integrating sustainability into its financing strategy to support its climate roadmap.
The bond supports sustainable finance, aligns with Green Finance Framework, and funds Next Generation Solutions and Technologies. It was oversubscribed, attracting sustainability-focused investors.
